Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Lacapère J[au]:

Insight into the Structural Features of TSPO: Implications for Drug Development. Lacapere JJ et al. Trends Pharmacol Sci. (2019)

Recombinant Overexpression of Mammalian TSPO Isoforms 1 and 2. Senicourt L et al. Methods Mol Biol. (2017)

Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria. Mirmiran A et al. Am J Hum Genet. (2019)

Search results

Items: 1 to 50 of 169

1.

Insight into the Structural Features of TSPO: Implications for Drug Development.

Lacapere JJ, Duma L, Finet S, Kassiou M, Papadopoulos V.

Trends Pharmacol Sci. 2019 Dec 18. pii: S0165-6147(19)30265-2. doi: 10.1016/j.tips.2019.11.005. [Epub ahead of print] Review.

PMID:
31864680
2.

Concentration, distribution, and influence of aging on the 18 kDa translocator protein in human brain: Implications for brain imaging studies.

Tong J, Williams B, Rusjan PM, Mizrahi R, Lacapère JJ, McCluskey T, Furukawa Y, Guttman M, Ang LC, Boileau I, Meyer JH, Kish SJ.

J Cereb Blood Flow Metab. 2019 Jun 20:271678X19858003. doi: 10.1177/0271678X19858003. [Epub ahead of print]

PMID:
31220997
3.

Characterization of the High-Affinity Drug Ligand Binding Site of Mouse Recombinant TSPO.

Iatmanen-Harbi S, Senicourt L, Papadopoulos V, Lequin O, Lacapere JJ.

Int J Mol Sci. 2019 Mar 21;20(6). pii: E1444. doi: 10.3390/ijms20061444.

4.

Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria.

Mirmiran A, Schmitt C, Lefebvre T, Manceau H, Daher R, Oustric V, Poli A, Lacapère JJ, Moulouel B, Puy H, Karim Z, Peoc'h K, Lenglet H, Simonin S, Deybach JC, Nicolas G, Gouya L.

Am J Hum Genet. 2019 Feb 7;104(2):341-347. doi: 10.1016/j.ajhg.2018.12.021. Epub 2019 Jan 31.

5.

Solid-State NMR of Membrane Protein Reconstituted in Proteoliposomes, the Case of TSPO.

Senicourt L, Duma L, Papadopoulos V, Lacapere JJ.

Methods Mol Biol. 2017;1635:329-344. doi: 10.1007/978-1-4939-7151-0_18.

PMID:
28755378
6.

Recombinant Overexpression of Mammalian TSPO Isoforms 1 and 2.

Senicourt L, Iatmanen-Harbi S, Hattab C, Ostuni MA, Giraud MF, Lacapere JJ.

Methods Mol Biol. 2017;1635:1-25. doi: 10.1007/978-1-4939-7151-0_1.

PMID:
28755361
7.

TSPO ligands stimulate ZnPPIX transport and ROS accumulation leading to the inhibition of P. falciparum growth in human blood.

Marginedas-Freixa I, Hattab C, Bouyer G, Halle F, Chene A, Lefevre SD, Cambot M, Cueff A, Schmitt M, Gamain B, Lacapere JJ, Egee S, Bihel F, Le Van Kim C, Ostuni MA.

Sci Rep. 2016 Sep 19;6:33516. doi: 10.1038/srep33516.

8.

A Central Cysteine Residue Is Essential for the Thermal Stability and Function of SUMO-1 Protein and SUMO-1 Peptide-Protein Conjugates.

Drobecq H, Boll E, Sénéchal M, Desmet R, Saliou JM, Lacapère JJ, Mougel A, Vicogne J, Melnyk O.

Bioconjug Chem. 2016 Jun 15;27(6):1540-6. doi: 10.1021/acs.bioconjchem.6b00211. Epub 2016 May 26.

PMID:
27195426
9.

Translocator Protein-Mediated Stabilization of Mitochondrial Architecture during Inflammation Stress in Colonic Cells.

Issop L, Ostuni MA, Lee S, Laforge M, Péranzi G, Rustin P, Benoist JF, Estaquier J, Papadopoulos V, Lacapère JJ.

PLoS One. 2016 Apr 7;11(4):e0152919. doi: 10.1371/journal.pone.0152919. eCollection 2016.

10.

Probing the gel to liquid-crystalline phase transition and relevant conformation changes in liposomes by (13)C magic-angle spinning NMR spectroscopy.

Purusottam RN, Sénicourt L, Lacapère JJ, Tekely P.

Biochim Biophys Acta. 2015 Dec;1848(12):3134-9. doi: 10.1016/j.bbamem.2015.09.011. Epub 2015 Sep 12.

11.

Construction and validation of an atomic model for bacterial TSPO from electron microscopy density, evolutionary constraints, and biochemical and biophysical data.

Hinsen K, Vaitinadapoule A, Ostuni MA, Etchebest C, Lacapere JJ.

Biochim Biophys Acta. 2015 Feb;1848(2):568-80. doi: 10.1016/j.bbamem.2014.10.028. Epub 2014 Oct 28.

12.

Genetic variation at KIT locus may predispose to melanoma.

Bourillon A, Hu HH, Hetet G, Lacapere JJ, André J, Descamps V, Basset-Seguin N, Ogbah Z, Puig S, Saiag P, Bagot M, Bensussan A, Grandchamp B, Dumaz N, Soufir N.

Pigment Cell Melanoma Res. 2013 Jan;26(1):88-96. doi: 10.1111/pcmr.12032. Epub 2012 Nov 23.

PMID:
23020152
13.

Mouse TSPO in a lipid environment interacting with a functionalized monolayer.

Teboul D, Beaufils S, Taveau JC, Iatmanen-Harbi S, Renault A, Venien-Bryan C, Vie V, Lacapere JJ.

Biochim Biophys Acta. 2012 Nov;1818(11):2791-800. doi: 10.1016/j.bbamem.2012.06.020. Epub 2012 Jul 4.

14.

A severe neonatal presentation of factor II deficiency.

Pasmant E, Dumont B, Lacapere JJ, Dautzenberg MD, Bezeaud A.

Eur J Haematol. 2011 Nov;87(5):464-6. doi: 10.1111/j.1600-0609.2011.01670.x. Epub 2011 Aug 11.

PMID:
21692854
15.

Combinatorial discovery of fluorescent pharmacophores by multicomponent reactions in droplet arrays.

Burchak ON, Mugherli L, Ostuni M, Lacapère JJ, Balakirev MY.

J Am Chem Soc. 2011 Jul 6;133(26):10058-61. doi: 10.1021/ja204016e. Epub 2011 Jun 14.

PMID:
21644551
16.

Subtle conformational changes between CX3CR1 genetic variants as revealed by resonance energy transfer assays.

Darbandi-Tehrani K, Hermand P, Carvalho S, Dorgham K, Couvineau A, Lacapère JJ, Combadière C, Deterre P.

FASEB J. 2010 Nov;24(11):4585-98. doi: 10.1096/fj.10-156612. Epub 2010 Jul 28.

PMID:
20667981
17.

From electron microscopy maps to atomic structures using normal mode-based fitting.

Hinsen K, Beaumont E, Fournier B, Lacapère JJ.

Methods Mol Biol. 2010;654:237-58. doi: 10.1007/978-1-60761-762-4_13.

PMID:
20665270
18.

Electron microscope tomography of native membranes.

Péranzi G, Messaoudi C, Issop L, Lacapère JJ.

Methods Mol Biol. 2010;654:221-35. doi: 10.1007/978-1-60761-762-4_12.

PMID:
20665269
19.

Bacterial overexpressed membrane proteins: an example: the TSPO.

Robert JC, Lacapère JJ.

Methods Mol Biol. 2010;654:29-45. doi: 10.1007/978-1-60761-762-4_3.

PMID:
20665260
20.

Characterization of membrane protein preparations: measurement of detergent content and ligand binding after proteoliposomes reconstitution.

Ostuni MA, Iatmanen S, Teboul D, Robert JC, Lacapère JJ.

Methods Mol Biol. 2010;654:3-18. doi: 10.1007/978-1-60761-762-4_1.

PMID:
20665258
21.

Overexpression of translocator protein in inflammatory bowel disease: potential diagnostic and treatment value.

Ostuni MA, Issop L, Péranzi G, Walker F, Fasseu M, Elbim C, Papadopoulos V, Lacapere JJ.

Inflamm Bowel Dis. 2010 Sep;16(9):1476-87. doi: 10.1002/ibd.21250.

22.

TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition.

Schaller S, Paradis S, Ngoh GA, Assaly R, Buisson B, Drouot C, Ostuni MA, Lacapere JJ, Bassissi F, Bordet T, Berdeaux A, Jones SP, Morin D, Pruss RM.

J Pharmacol Exp Ther. 2010 Jun;333(3):696-706. doi: 10.1124/jpet.110.167486. Epub 2010 Mar 9.

PMID:
20215409
23.

Translocator protein (18 kDa) is involved in primitive erythropoiesis in zebrafish.

Rampon C, Bouzaffour M, Ostuni MA, Dufourcq P, Girard C, Freyssinet JM, Lacapere JJ, Schweizer-Groyer G, Vriz S.

FASEB J. 2009 Dec;23(12):4181-92. doi: 10.1096/fj.09-129262. Epub 2009 Sep 1.

PMID:
19723704
24.

Design and humanization of a murine scFv that blocks human platelet glycoprotein VI in vitro.

Muzard J, Bouabdelli M, Zahid M, Ollivier V, Lacapère JJ, Jandrot-Perrus M, Billiald P.

FEBS J. 2009 Aug;276(15):4207-22. doi: 10.1111/j.1742-4658.2009.07129.x. Epub 2009 Jun 25.

25.

Variants of the xeroderma pigmentosum variant gene (POLH) are associated with melanoma risk.

Di Lucca J, Guedj M, Lacapère JJ, Fargnoli MC, Bourillon A, Dieudé P, Dupin N, Wolkenstein P, Aegerter P, Saiag P, Descamps V, Lebbe C, Basset-Seguin N, Peris K, Grandchamp B, Soufir N.

Eur J Cancer. 2009 Dec;45(18):3228-36. doi: 10.1016/j.ejca.2009.04.034. Epub 2009 May 26.

PMID:
19477635
26.

Distribution, pharmacological characterization and function of the 18 kDa translocator protein in rat small intestine.

Ostuni MA, Péranzi G, Ducroc RA, Fasseu M, Vidic B, Dumont J, Papadopoulos V, Lacapere JJ.

Biol Cell. 2009 Jul 31;101(10):573-86. doi: 10.1042/BC20080231.

PMID:
19392661
27.

Characterization of a functional NTPDase in the endoplasmic reticulum of rat submandibular salivary gland.

Ostuni MA, Egido P, Peranzi G, Alonso GL, Lacapere JJ, Gonzalez DA.

Physiol Res. 2009;58(6):843-54. Epub 2008 Dec 17.

28.

Xeroderma pigmentosum group C in a French Caucasian patient with multiple melanoma and unusual long-term survival.

Jacobelli S, Soufir N, Lacapere JJ, Regnier S, Bourillon A, Grandchamp B, Hétet G, Pham D, Palangie A, Avril MF, Dupin N, Sarasin A, Gorin I.

Br J Dermatol. 2008 Sep;159(4):968-73. doi: 10.1111/j.1365-2133.2008.08791.x. Epub 2008 Aug 20.

PMID:
18717677
29.

Production and purification of large quantities of the functional N-terminal ectodomain of human VPAC1 receptor.

Couvineau A, Robert JC, Ramdani T, Lacapère JJ, Rouyer-Fessard C, Laburthe M.

J Mol Neurosci. 2008 Nov;36(1-3):249-53. doi: 10.1007/s12031-008-9072-8. Epub 2008 Jul 1.

PMID:
18592417
30.

Class-B GPCR activation: is ligand helix-capping the key?

Neumann JM, Couvineau A, Murail S, Lacapère JJ, Jamin N, Laburthe M.

Trends Biochem Sci. 2008 Jul;33(7):314-9. doi: 10.1016/j.tibs.2008.05.001. Epub 2008 Jun 12.

PMID:
18555686
31.

Secondary and tertiary structures of the transmembrane domains of the translocator protein TSPO determined by NMR. Stabilization of the TSPO tertiary fold upon ligand binding.

Murail S, Robert JC, Coïc YM, Neumann JM, Ostuni MA, Yao ZX, Papadopoulos V, Jamin N, Lacapère JJ.

Biochim Biophys Acta. 2008 Jun;1778(6):1375-81. doi: 10.1016/j.bbamem.2008.03.012. Epub 2008 Mar 27.

32.

Effect of translocator protein (18 kDa)-ligand binding on neurotransmitter-induced salivary secretion in rat submandibular glands.

Ostuni MA, Tumilasci OR, Péranzi G, Cardoso EM, Contreras LN, Arregger AL, Papadopoulos V, Lacapere JJ.

Biol Cell. 2008 Jul;100(7):427-39. doi: 10.1042/BC20070157.

PMID:
18269350
34.

TLR9 activation induces normal neutrophil responses in a child with IRAK-4 deficiency: involvement of the direct PI3K pathway.

Hoarau C, Gérard B, Lescanne E, Henry D, François S, Lacapère JJ, El Benna J, Dang PM, Grandchamp B, Lebranchu Y, Gougerot-Pocidalo MA, Elbim C.

J Immunol. 2007 Oct 1;179(7):4754-65.

35.
36.

Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis.

Bordet T, Buisson B, Michaud M, Drouot C, Galéa P, Delaage P, Akentieva NP, Evers AS, Covey DF, Ostuni MA, Lacapère JJ, Massaad C, Schumacher M, Steidl EM, Maux D, Delaage M, Henderson CE, Pruss RM.

J Pharmacol Exp Ther. 2007 Aug;322(2):709-20. Epub 2007 May 11.

PMID:
17496168
37.

Determining membrane protein structures: still a challenge!

Lacapère JJ, Pebay-Peyroula E, Neumann JM, Etchebest C.

Trends Biochem Sci. 2007 Jun;32(6):259-70. Epub 2007 May 3. Review.

PMID:
17481903
38.

A French CDK4-positive melanoma family with a co-inherited EDNRB mutation.

Soufir N, Ollivaud L, Bertrand G, Lacapère JJ, Descamps V, Vitoux D, Lebbe C, Wolkenstein P, Dupin N, Saiag P, Basset-Seguin N, Grandchamp B; MELAN-COHORT.

J Dermatol Sci. 2007 Apr;46(1):61-4. Epub 2007 Jan 12. No abstract available.

PMID:
17223014
39.

Characterization of the new photoaffinity probe (Bz2-K24)-VIP.

Tan YV, Couvineau A, Lacapere JJ, Laburthe M.

Ann N Y Acad Sci. 2006 Jul;1070:575-80.

PMID:
16888228
40.

The human VPAC1 receptor: identification of the N-terminal ectodomain as a major VIP-binding site by photoaffinity labeling and 3D modeling.

Couvineau A, Tan YV, Ceraudo E, Lacapère JJ, Murail S, Neumann JM, Laburthe M.

Ann N Y Acad Sci. 2006 Jul;1070:205-9.

PMID:
16888167
41.

Spatial approximation between the C-terminus of VIP and the N-terminal ectodomain of the VPAC1 receptor.

Ceraudo E, Tan YV, Couvineau A, Lacapere JJ, Laburthe M.

Ann N Y Acad Sci. 2006 Jul;1070:180-4.

PMID:
16888162
42.

Chimeric Fc receptors identify ligand binding regions in human glycoprotein VI.

Dumont B, Minullina I, Loyau S, Monteiro RC, Lacapere JJ, Arocas V, Jandrot-Perrus M.

J Mol Biol. 2006 Sep 1;361(5):877-87. Epub 2006 Jul 7.

PMID:
16876821
43.

Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function.

Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapère JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M.

Trends Pharmacol Sci. 2006 Aug;27(8):402-9. Epub 2006 Jul 5. Review.

PMID:
16822554
44.
45.

Peptide agonist docking in the N-terminal ectodomain of a class II G protein-coupled receptor, the VPAC1 receptor. Photoaffinity, NMR, and molecular modeling.

Tan YV, Couvineau A, Murail S, Ceraudo E, Neumann JM, Lacapère JJ, Laburthe M.

J Biol Chem. 2006 May 5;281(18):12792-8. Epub 2006 Mar 6.

46.

Association between endothelin receptor B nonsynonymous variants and melanoma risk.

Soufir N, Meziani R, Lacapère JJ, Bertrand G, Fumeron F, Bourillon A, Gérard B, Descamps V, Crickx B, Ollivaud L, Archimbaud A, Lebbe C, Basset-Seguin N, Saiag P, Grandchamp B; Investigators of the Melan-Cohort.

J Natl Cancer Inst. 2005 Sep 7;97(17):1297-301.

PMID:
16145050
47.

[A new role for peripheral benzodiazepine receptor?].

Ostuni MA, Lacapère JJ.

Med Sci (Paris). 2005 Mar;21(3):240-2. French. No abstract available.

48.

Structural studies of a stabilized phosphoenzyme intermediate of Ca2+-ATPase.

Stokes DL, Delavoie F, Rice WJ, Champeil P, McIntosh DB, Lacapère JJ.

J Biol Chem. 2005 May 6;280(18):18063-72. Epub 2005 Feb 25.

49.

Normal mode-based fitting of atomic structure into electron density maps: application to sarcoplasmic reticulum Ca-ATPase.

Hinsen K, Reuter N, Navaza J, Stokes DL, Lacapère JJ.

Biophys J. 2005 Feb;88(2):818-27. Epub 2004 Nov 12.

50.

Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor.

Jamin N, Neumann JM, Ostuni MA, Vu TK, Yao ZX, Murail S, Robert JC, Giatzakis C, Papadopoulos V, Lacapère JJ.

Mol Endocrinol. 2005 Mar;19(3):588-94. Epub 2004 Nov 4.

PMID:
15528269

Supplemental Content

Loading ...
Support Center